From the Director: March-in authority to control drug prices ultimately hurts Americans
Todd Sherer, PhD is the Associate VP for Research and Executive Director of the Emory University Office of Technology Transfer. In this article, Todd reflects on the Bayh-Dole Act and provides a lesson on march-in authority as outlined in the law. Before the bipartisan Bayh-Dole Act was passed in 1980, no federally funded drugs, vaccines, or products were commercialized and brought to market. This was because the government, not the inventing organizations, took ownership of the patent. At a time when American industrialism was threatened, the Bayh-Dole Act strengthened U.S. competitiveness. In the past, activists have tried to challenge Bayh-Dole Read More …